A recent study in the journal Stroke found that stroke treatment using intravenous thrombolysis costs U.S. hospitals much more than Medicare pays. Researchers found that it costs, on average, $14,102 for a hospital to provide treatment to a patient with a good medical outcome, and Medicare pays $10,098. Authorities said this kind of cost discrepancy could make hospitals reluctant to open stroke treatment centers and offer treatments that lose money.